The efficacy and safety of potassium clavulanate/amoxicillin (CLAVAMOX®) dry syrup in children with otitis media

Japanese Journal of Antibiotics

Volumn 60, Issue 4, 2007, Pages 221-241

  Sugita, Rinya ^a   Yamanaka, Noboru ^b   Kudo, Fumiyo ^c   Ito, Rie ^d   Kawai, Motoji ^d   Ohwaki, Ichiro ^d   Asano, Satoshi ^d   Nagata, Tsutae ^d  

^a Sugita Otorhinolaryngology Clinic

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c CHIBA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^d Development and Medical Affairs Division   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

AGE DISTRIBUTION; ARTICLE; BACTERIAL STRAIN; DATA ANALYSIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; INFORMATION PROCESSING; MORAXELLA; OTALGIA; OTITIS MEDIA; OTORRHEA; STREPTOCOCCUS PNEUMONIAE;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CHILD; CHILD, PRESCHOOL; DOSAGE FORMS; DRUG TOXICITY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; MORAXELLA (BRANHAMELLA) CATARRHALIS; OTITIS MEDIA; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 34548864648     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Japanese source
2. TELLE, D. W.; J. O. KLEIN & B. A. ROSNER: Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160: 83-94, 1989
3. Japanese source
4. Japanese source
5. Japanese source
6. DOWELL, S. F.; J. C. BUTLER, G. S. GIEBINK, et al.: Acute Otitis media: management and surveillance in an era of pneumococcal resistance - a report from the drug-resistant Streptococcus pneumoniae therapeutic working group. Pediatr. Infect. Dis. J. 18: 1-9, 1999
7. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media : Diagnosis and Management of Acute Otitis Media. Pediatrics 113: 1451-1465, 2004
8. Japanese source
9. BOTTENFIELD, G. W.; D. J. BURCH, J. A. HEDRICK, et al.: Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin®) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae. Pediatr. Infect. Dis. J. 17: 963-968, 1998
10. Japanese source
11. Japanese source
12. Japanese source
13. Japanese source
14. SAKAI, A.; M. HOTOMI, N. YAMANAKA, et al.: Evaluation of mutations in penicillin binding protein-3 gene of non-typeable Haemophilus influenzae isolated from the nasopharynx of children with acute otitis media. Acta Otolaryngol. 125: 180-183, 2005
15. Japanese source
16. Japanese source
17. Japanese source
18. HOTOMI, M.; N. YAMANAKA, J. SHIMADA, et al.: Factors associated with clinical outcomes in acute otitis media. Ann. Otol. Rhinol. Laryngol. 113: 846-852, 2004
19. Japanese source
20. Japanese source
21. Japanese source
22. Japanese source